Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Patulous eustachian tube after percutaneous balloon microcompression for trigeminal neuralgia: case report.
Microparticles: A New Perspective in Central Nervous System Disorders.
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.
Iron and multiple sclerosis.
Sex and gender issues in multiple sclerosis.
No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients.
Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
Does robot-assisted gait training ameliorate gait abnormalities in multiple sclerosis? A pilot randomized-control trial.
Toxicological aspects of injectable gold-hyaluronan combination as a treatment for neuroinflammation.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Induction of recombinase activity in peripheral T cells in multiple sclerosis.
Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis.
The effect of exercise training on fitness in multiple sclerosis: A meta-analysis.
Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Aquaporin-4 autoimmunity.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
An early British case of neuromyelitis optica (1850).
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
Botulinum Toxin-What Urologic Uses Does the Data Support?
Multiple sclerosis in New Zealand.
Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.
The RESTORE trial: What did we learn about multiple sclerosis?

Pages